
Minoxidil (5% w/v) + Finasteride (0.1% w/v)
Active composition
+1 more active ingredient
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Medical applications
Kazegrow-F Solution is a topical formulation containing Minoxidil 5% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult males. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and stimulating hair follicle cells, thereby prolonging the anagen phase of the hair cycle. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combination therapy targets multiple pathogenic mechanisms of male pattern baldness, offering improved efficacy compared to monotherapy. Kazegrow-F Solution is applied topically to the affected scalp areas once daily, ensuring localized action with minimal systemic absorption. Clinical studies have demonstrated significant improvement in hair density and thickness with consistent use over several months. Patients should be advised regarding potential side effects, including scalp irritation, itching, and rare systemic effects related to Finasteride. Use is contraindicated in women and children, and caution is advised in patients with hypersensitivity to any component. Regular follow-up is recommended to assess therapeutic response and monitor for adverse reactions. Kazegrow-F Solution provides a clinically effective option for managing male androgenetic alopecia with a well-established safety profile.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kazegrow-F Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Kazegrow-F Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Kazegrow-F Solution

Minoxidil (5% w/v) + Finasteride (0.1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Minoxidil opens potassium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance.
Finasteride inhibits the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone responsible for prostate growth and hair loss.
Medical applications
Kazegrow-F Solution is a topical formulation containing Minoxidil 5% w/v and Finasteride 0.1% w/v, indicated for the treatment of androgenetic alopecia in adult males. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and stimulating hair follicle cells, thereby prolonging the anagen phase of the hair cycle. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key factor implicated in hair follicle miniaturization and progressive hair loss. The combination therapy targets multiple pathogenic mechanisms of male pattern baldness, offering improved efficacy compared to monotherapy. Kazegrow-F Solution is applied topically to the affected scalp areas once daily, ensuring localized action with minimal systemic absorption. Clinical studies have demonstrated significant improvement in hair density and thickness with consistent use over several months. Patients should be advised regarding potential side effects, including scalp irritation, itching, and rare systemic effects related to Finasteride. Use is contraindicated in women and children, and caution is advised in patients with hypersensitivity to any component. Regular follow-up is recommended to assess therapeutic response and monitor for adverse reactions. Kazegrow-F Solution provides a clinically effective option for managing male androgenetic alopecia with a well-established safety profile.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Kazegrow-F Solution is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
High Risk
Kazegrow-F Solution is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby. Not indicated for use in women.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Kazegrow-F Solution















